oncolytic virus Archives -

Daiichi Sankyo has launched its oncolytic virus therapy Delytact in Japan – its first world market – as

First launch for Daiichi Sankyo’s oncolytic virus Delytact in Japan

https://pharmaphorum.com/news/first-launch-for-daiichi-sankyos-oncolytic-virus-delytact-in-japan/

Daiichi Sankyo has made a little bit of pharma industry history, becoming the first drugmaker to win approval

Daiichi Sankyo claims first okay for oncolytic virus in Japan

https://pharmaphorum.com/news/daiichi-sankyo-claims-first-okay-for-cancer-killing-virus-in-japan/

South Korean biotech Sillajen was hit hard last week when its oncolytic virus therapy Pexa-Vec failed a phase

Sillajen explains Pexa-Vec trial failure – it was the rescue meds

https://pharmaphorum.com/news/sillajen-explains-pexa-vec-trial-failure-it-was-the-rescue-meds/

Big pharma pays 160% premium for Australian biotech

Immunotherapy arms race latest: Merck buys Viralytics for $394m

https://pharmaphorum.com/news/merck-co-buy-viralytics-cancer-killing-virus-394m/

oncolytic virus